Pardes Biosciences Appoints Thomas G. Wiggans to CEO and
Mr. Wiggans brings over 40 years of biopharmaceutical industry experience, including over 25 years in chief executive leadership roles with multiple...
Stay updated with breaking news from Pardes Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mr. Wiggans brings over 40 years of biopharmaceutical industry experience, including over 25 years in chief executive leadership roles with multiple...
02.03.2022 - Mr. Wiggans brings over 40 years of biopharmaceutical industry experience, including over 25 years in chief executive leadership roles with multiple successful acquisitions. His expertise will be beneficial to Pardes as the company rapidly ... Seite 1
The Carlsbad startup is in early clinical trials for an experimental antiviral oral treatment for COVID-19, akin to Tamiflu for influenza.
Startup is in early clinical trials for an experimental antiviral oral treatment for COVID-19, akin to Tamiflu for influenza.